Dzana Dervovic

617 total citations
12 papers, 251 citations indexed

About

Dzana Dervovic is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Dzana Dervovic has authored 12 papers receiving a total of 251 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Dzana Dervovic's work include T-cell and B-cell Immunology (6 papers), Immune Cell Function and Interaction (6 papers) and CAR-T cell therapy research (4 papers). Dzana Dervovic is often cited by papers focused on T-cell and B-cell Immunology (6 papers), Immune Cell Function and Interaction (6 papers) and CAR-T cell therapy research (4 papers). Dzana Dervovic collaborates with scholars based in Canada, United States and Australia. Dzana Dervovic's co-authors include Juan Carlos Zúñiga‐Pflücker, Dalam Ly, Mahmood Mohtashami, Feng Liu, Junlin Yao, Jong Bok Lee, Imir G. Metushi, Gisele Knowles, Hyeonjeong Kang and Li Zhang and has published in prestigious journals such as Nature Communications, Blood and The Journal of Immunology.

In The Last Decade

Dzana Dervovic

12 papers receiving 249 citations

Peers

Dzana Dervovic

IMMUN

ONCOL

HEMAT

PHARM

David Posocco United States

Juozas Vasiliauskas United States

Yamel Cardona Gloria Germany

Stine Kiær Larsen Denmark

Hilary R. Keller United States

Sebastian Bittner Germany

Caterina Mezzatesta Italy

Andrea Nicola Mazzarello United States

Yuxuan Che United States

Ruby M. Stewart United States

David Posocco United States

Dzana Dervovic

100 ×0.8

IMMUN

79 ×0.7

ONCOL

187 ×2.1

45 ×1.6

HEMAT

10 ×0.4

PHARM

Citations per year, relative to Dzana Dervovic Dzana Dervovic (= 1×) peers David Posocco

Countries citing papers authored by Dzana Dervovic

Since Specialization

Citations

This map shows the geographic impact of Dzana Dervovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dzana Dervovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dzana Dervovic more than expected).

Fields of papers citing papers by Dzana Dervovic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dzana Dervovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dzana Dervovic. The network helps show where Dzana Dervovic may publish in the future.

Co-authorship network of co-authors of Dzana Dervovic

This figure shows the co-authorship network connecting the top 25 collaborators of Dzana Dervovic. A scholar is included among the top collaborators of Dzana Dervovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dzana Dervovic. Dzana Dervovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Martinez, Sébastien, Ahmad Malik, Ramona Weber, et al.. (2024). In vivo CRISPR screens reveal SCAF1 and USP15 as drivers of pancreatic cancer. Nature Communications. 15(1). 5266–5266. 8 indexed citations

Malik, Ahmad, Dzana Dervovic, Ricky Tsai, et al.. (2023). The NOTCH-RIPK4-IRF6-ELOVL4 Axis Suppresses Squamous Cell Carcinoma. Cancers. 15(3). 737–737. 14 indexed citations

Yao, Junlin, Dalam Ly, Dzana Dervovic, et al.. (2019). Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15. Journal for ImmunoTherapy of Cancer. 7(1). 17–17. 55 indexed citations

Dervovic, Dzana, et al.. (2018). The orphan nuclear receptor EAR-2 (NR2F6) inhibits hematopoietic cell differentiation and induces myeloid dysplasia in vivo. Biomarker Research. 6(1). 36–36. 8 indexed citations

Dervovic, Dzana, Dalam Ly, T. Haug, et al.. (2018). Infusion ofex-vivoexpanded human TCR-αβ+ double-negative regulatory T cells delays onset of xenogeneic graft-versus-host disease. Clinical & Experimental Immunology. 193(3). 386–399. 26 indexed citations

Metushi, Imir G., Ping Cai, Dzana Dervovic, et al.. (2014). Development of a novel mouse model of amodiaquine-induced liver injury with a delayed onset. Journal of Immunotoxicology. 12(3). 247–260. 34 indexed citations

Dervovic, Dzana, et al.. (2013). The orphan nuclear receptor Ear-2 (Nr2f6) is a novel negative regulator of T cell development. Experimental Hematology. 42(1). 46–58. 15 indexed citations

Dervovic, Dzana, Jennifer L. Cannons, Alisha R. Elford, et al.. (2013). Cellular and Molecular Requirements for the Selection of In Vitro–Generated CD8 T Cells Reveal a Role for Notch. The Journal of Immunology. 191(4). 1704–1715. 14 indexed citations

Benveniste, Patricia, Pablo Catalán, Dzana Dervovic, et al.. (2013). Notch signals are required for in vitro but not in vivo maintenance of human hematopoietic stem cells and delay the appearance of multipotent progenitors. Blood. 123(8). 1167–1177. 37 indexed citations

10.

Dervovic, Dzana, et al.. (2012). Comparative and Functional Evaluation of In Vitro Generated to Ex Vivo CD8 T Cells. The Journal of Immunology. 189(7). 3411–3420. 17 indexed citations

11.

Dervovic, Dzana & Juan Carlos Zúñiga‐Pflücker. (2010). Positive selection of T cells, an in vitro view. Seminars in Immunology. 22(5). 276–286. 22 indexed citations

12.

Dervovic, Dzana, et al.. (2009). The Orphan Nuclear Receptor NR2F6 Is a Novel Negative Regulator of T-Cell Development.. Blood. 114(22). 915–915. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact